Sartoris D J
Department of Radiology, University of California, San Diego, Medical Center 92103-8756.
AJR Am J Roentgenol. 1994 Jul;163(1):133-5. doi: 10.2214/ajr.163.1.8010199.
The purpose of this article is to provide insight into the long-standing controversy over the clinical value of noninvasive measurement of bone mass. Results of recent studies have increasingly supported the judicious use of bone densitometry as a clinical tool [1]. These reports contradict editorials on the limitations of bone densitometry that have appeared in a variety of subspecialty publications [2,3]. The importance of bone mass measurement is underscored by the lack of success in predicting bone density from various combinations of anthropometric and historical variables. Growing evidence suggests that densitometry is a useful tool for determining which women near menopause are at risk for osteoporosis and, therefore, are candidates for estrogen-replacement therapy. This article summarizes current concepts on the subject and attempts to prove that bone densitometry is a beneficial and indicated procedure for selected patients.
本文旨在深入探讨关于骨量无创测量临床价值的长期争议。近期研究结果越来越支持明智地使用骨密度测定法作为一种临床工具[1]。这些报告与各种专科出版物中出现的关于骨密度测定法局限性的社论相矛盾[2,3]。由于从各种人体测量学和病史变量的组合中预测骨密度均未成功,骨量测量的重要性得到了凸显。越来越多的证据表明,骨密度测定法是一种有用的工具,可用于确定哪些接近绝经的女性有患骨质疏松症的风险,因此是雌激素替代疗法的候选对象。本文总结了关于该主题的当前概念,并试图证明骨密度测定法对选定患者是一种有益且适用的程序。